We are live on
!
Find out more
SFG
SVB Financial Group Portfolio holdings
AUM
$434K
1-Year Est. Return
277.67%
This Fund
S&P 500
This Quarter
Est. Return
+110.07%
1 Year Est. Return
+277.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$59.7M
(+112%)
Cap. Flow
+$9.4M
Cap. Flow
% of AUM
8.33%
Top 10 Holdings %
Top 10 Hldgs %
99.96%
Holding
23
New
2
Increased
2
Reduced
1
Closed
10
Avg Time Held
2.9
quarters
Top 10 Avg Time Held
2.1
quarters
Top 20 Avg Time Held
2.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coinbase
COIN
|
+$13.6M |
| 2 |
MoneyLion Inc.
ML
|
+$125K |
| 3 |
Pacific Biosciences
PACB
|
+$84.5K |
| 4 |
Getaround, Inc.
GETR
|
+$6.03K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Structure Therapeutics
GPCR
|
+$1.78M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
+$922K |
| 3 |
Rover Group, Inc. Class A Common Stock
ROVR
|
+$661K |
| 4 |
CareMax, Inc. Class A Common Stock
CMAX
|
+$636K |
| 5 |
Cullinan Oncology
CGEM
|
+$122K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 89.38% |
| 2 | Technology | 6.38% |
| 3 | Healthcare | 3.6% |
| 4 | Industrials | 0.38% |
| 5 | Consumer Discretionary | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Coinbase
COIN
$47.6B
| $92.4M | 81.9% |
531,319
+124,346
| +31% | +$13.6M |
2022 Q4
4 quarters
|
|
2
Root
ROOT
$749M
| $8.21M | 7.27% |
783,012
| – | – |
2022 Q4
4 quarters
|
|
3
Okta
OKTA
$39.7B
| $7.17M | 6.35% |
79,152
| – | – |
2022 Q4
4 quarters
|
|
4
Axsome Therapeutics
AXSM
$8.7B
| $2.69M | 2.39% |
33,849
| – | – |
2022 Q4
4 quarters
|
|
5
Orchestra BioMed
OBIO
$355M
| $1.16M | 1.03% |
127,068
| – | – |
2023 Q1
3 quarters
|
|
6
Planet Labs
PL
$5.81B
| $425K | 0.38% |
172,097
| – | – |
2022 Q4
4 quarters
|
|
|
7
DELISTED
MoneyLion Inc.
ML
| $234K | 0.21% |
+3,729
| New | +$125K |
2023 Q4
0 quarters
|
|
8
Global E Online
GLBE
$6.55B
| $203K | 0.18% |
5,114
| – | – |
2023 Q2
2 quarters
|
|
|
9
Pacific Biosciences
PACB
$653M
| $202K | 0.18% |
20,586
+10,337
| +101% | +$84.5K |
2022 Q4
4 quarters
|
|
10
Firy Inc
FIRY
$206M
| $86.8K | 0.08% |
13,950
| – | – |
2022 Q4
4 quarters
|
|
|
MVLA
11
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $33.6K | 0.03% |
55,528
| – | – |
2023 Q1
3 quarters
|
|
|
12
DELISTED
Getaround, Inc.
GETR
| $6.37K | 0.01% |
+27,094
| New | +$6.03K |
2023 Q4
0 quarters
|
|
|
MKUL
13
DELISTED
Molekule Group, Inc. Common Stock
MKUL
| $142 | ﹤0.01% |
14,165
-7,082
| -33% | -$862 |
2023 Q2
2 quarters
|
|
|
14
Cullinan Oncology
CGEM
$962M
| – | – |
-13,516
| Closed | -$122K | – |
|
15
Caribou Biosciences
CRBU
$53.3M
| – | – |
-20,714
| Closed | -$99K | – |
|
16
Eledon Pharmaceuticals
ELDN
$198M
| – | – |
-13,472
| Closed | -$18.5K | – |
|
17
DELISTED
Generation Bio
GBIO
| – | – |
-2,503
| Closed | -$94.9K | – |
|
|
18
Structure Therapeutics
GPCR
$1.71B
| – | – |
-35,353
| Closed | -$1.78M | – |
|
|
19
MoonLake Immunotherapeutics
MLTX
$909M
| – | – |
-16,173
| Closed | -$922K | – |
|
20
DELISTED
Venus Concept
VERO
| – | – |
-970
| Closed | -$20.9K | – |
|
21
Kalaris Therapeutics
KLRS
$53.8M
| – | – |
-748
| Closed | -$37K | – |
|
|
22
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| – | – |
-105,534
| Closed | -$661K | – |
|
|
23
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| – | – |
-10,000
| Closed | -$636K | – |
|
Similar funds
RCMC
CBFP
BP
SLA
SG
AFG
K
MIG
SVB Financial Group's Q4 2023 Portfolio in Review
As of Q4 2023, SVB Financial Group held 23 positions worth $113M, up 112% from $53.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
SVB Financial Group deployed $9.4M of net new capital in Q4 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was MoneyLion Inc.: 3,729 shares worth $234K.
By sector, the portfolio is most concentrated in Financials at 89% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Molekule Group, Inc. Common Stock, an estimated $862 trimmed.
- SVB Financial Group's largest Q4 2023 buy was MoneyLion Inc.: 3,729 shares worth $234K.
- SVB Financial Group added most to Coinbase in Q4 2023, an estimated $13.6M increase.
- SVB Financial Group's biggest Q4 2023 reduction was Molekule Group, Inc. Common Stock, cutting an estimated $862.
- SVB Financial Group fully exited Structure Therapeutics in Q4 2023, selling an estimated $1.78M.
- SVB Financial Group's ten largest holdings make up 100% of its $113M portfolio in Q4 2023.
- SVB Financial Group opened 2 new positions and closed 10 in Q4 2023.
- SVB Financial Group's portfolio value rose 112% quarter-over-quarter to $113M.
Based on SVB Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.